ESC/EAS Guidelines for the management of dyslipidaemias

被引：62

作者：

Reiner, Zeljko ^{[1
]}

Catapano, Alberico L. ^{[2
]}

De Backer, Guy

Graham, Ian

Taskinen, Marja-Riitta

Wiklund, Olov

Agewall, Stefan

Alegria, Eduardo

Chapman, M. John

Durrington, Paul

Erdine, Serap

Halcox, Julian

Hobbs, Richard

Kjekshus, John

Filardi, Pasquale Perrone

Riccardi, Gabriele

Storey, Robert F.

Wood, David

机构：

[1] Univ Zagreb, Sch Med, Univ Hosp Ctr Zagreb, Zagreb 10000, Croatia

[2] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy

来源：

EUROPEAN HEART JOURNAL | 2011年 / 32卷 / 14期

关键词：

Dyslipidaemia; Cholesterol; Triglycerides; Treatment; Cardiovascular diseases; Guidelines; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR RISK-FACTORS; HIGH-DOSE ATORVASTATIN; POLYUNSATURATED FATTY-ACIDS; TYPE-2; DIABETES-MELLITUS; EXTENDED-RELEASE NIACIN; STATIN-TREATED PATIENTS; LIPID-LOWERING THERAPY; HIV-INFECTED PATIENTS;

D O I：

10.1093/eurheartj/ehr158

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1769 / 1818

页数：50

共 50 条

[31] The changing landscape of lipid-lowering therapy after the new ESC/EAS guidelines for the management of dyslipidaemias: Launching the era of triple hypolipidaemic therapy in very high risk patients
Rallidis, Loukianos S.
ATHEROSCLEROSIS, 2020, 292 : 231 - 233
[32] The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011
Ray, Kausik K.
Kastelein, John J. P.
Boekholdt, S. Matthijs
Nicholls, Stephen J.
Khaw, Kay-Tee
Ballantyne, Christie M.
Catapano, Alberico L.
Reiner, Zeljko
Luescher, Thomas F.
EUROPEAN HEART JOURNAL, 2014, 35 (15) : 960 - 968
[33] Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias (vol 73, pg 348, 2020)
REVISTA ESPANOLA DE CARDIOLOGIA, 2021, 74 (03): : 283 - 283
[34] Comments on the guidelines (2019) of the ESC/EAS on the diagnostics and treatment of dyslipidemias
Weingartnerl, Oliver
Landmesser, Ulf
Marz, Winfried
Katzmann, Julius L.
Laufs, Ulrich
KARDIOLOGE, 2020, 14 (04): : 256 - 266
[35] The first European Guidelines focussed on: Management of dyslipidaemias
Taylor, Jennifer
EUROPEAN HEART JOURNAL, 2011, 32 (16) : 1949 - 1950
[36] ESC-Leitlinie Dyslipidämien: die 10 KernbotschaftenKritische BewertungCritical review of the ESC Guidelines 2019 for the management of dyslipidaemias in 10 key-messages
Kai Toussaint
Claudia Brückner
MMW - Fortschritte der Medizin, 2020, 162 (10) : 45 - 48
[37] Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias(vol 70, pg 72 yr 2017)
Catapano, Alberico L.
Graham, Ian
De Backer, Guy
Wiklund, Olov
Chapman, M. John
Drexel, Heinz
Hoes, Arno W.
Jennings, Catriona S.
Landmesser, Ulf
Pedersen, Terje R.
Reiner, Zeljko
Riccardi, Gabriele
Taskinen, Marja-Riita
Tokozoglu, Lale
Monique Verschuren, W. M.
Vlachopoulos, Charalambos
Wood, David A.
Luis Zamorano, Jose
REVISTA ESPANOLA DE CARDIOLOGIA, 2018, 71 (06): : 509 - 510
[38] News from the literature: Focus on joint ESC/EAS dyslipidemia guidelines
Stock, Jane
ATHEROSCLEROSIS, 2012, 220 (01) : 42 - 44
[39] New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines
Raygor, Viraj
Khera, Amit
CURRENT CARDIOLOGY REPORTS, 2020, 22 (09)
[40] Comments on the 2011 ESC/EAS guidelines for the management of dyslipidemias. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology
Anguita, Manuel
Alegria, Eduardo
Barrios, Vivencio
Casasnovas, Jose A.
Escobar, Carlos
Leon, Monserrat
Luengo, Emilio
Llisterri, Jose L.
REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (12): : 1090 - 1095

← 1 2 3 4 5 →